Clinical Trial

NOACs Use in AF or VTE (SUNSHINE Registry)

Recruiting
View on ClinicalTrials.gov →
Summary
The outcomes regiStry for non-vitamin k antagonist oral anticoagUlants treatmeNt in variouS tHrombotIc dIseases for better cliNical practicE (SUNSHINE) is a multicenter, prospective, observational non-interventional inpatient/outpatient disease registry to assess the utilization of Non-vitamin k antagonist oral anticoagulants (NOACs), and associated outcomes. The SUNSHINE registry will focus on the collection and analysis of observational data in medical records from hospital information system (HIS) to evaluate the outcomes related with these NOACs when applied in extensive patient populations outside of clinical research studies. The registry will also allow for mainly combining the atrial fibrillation (AF) and venous thromboembolism (VTE) databases. In brief, the SUNSHINE registry will provide important information on the outcomes of NOACs in routine practice and gather further information on its safety and effectiveness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-05-12.
Status change: Not Yet Recruiting → Recruiting 2022-06-06
Trial Details
NCT Number NCT05378308
Lead Sponsor Henan Provincial People's Hospital
Conditions Atrial Fibrillation, Venous Thromboembolism, Oral Anticoagulant
Enrollment 5,000 participants
Start Date 2022-06-06
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2022-06-09